Resources

Our community of economists and academic leaders from around the United States are united in their belief that more competition, innovation, accountability, consumer choice, and transparency are needed in America’s healthcare sector to improve the health and well-being of every patient.

Why the High Cost of New Drugs Might Be a Bargain

November 30, 2023

Columbia Business School

By Beth Weinhouse
CBS Professor Frank Lichtenberg’s research shows that new pharmaceuticals more than pay for themselves through health and productivity gains, and offset medical costs.

Outcomes of the 340B Drug Pricing Program: A Scoping Review

November 22, 2023

JAMA Network

By Ryan Know, Junyi Wang, and William Feldman

Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy

November 3, 2023

JAMA Network

By T. Joseph Mattingly II, David Hyman, and Gei Bai

The 340B Drug Pricing Program: Litigation, Administration, and Reform

September 28, 2023

SSRN

By Ryan Knox and Ameet Sarpatwari

Procompetitive Health Care Reform Options for a Divided Congress

March 16, 2023

USC Schaeffer and Brookings Institution

By Loren Adler and Benedic Ippolito
Scroll to Top